Trulicity 0.75mg?

Trulicity (dulaglutide) – 0.75 mg

Trulicity is the brand name for the once‑weekly injectable drug dulaglutide, a glucagon‑like peptide‑1 (GLP‑1) receptor agonist. It’s approved for use in adults with type 2 diabetes to help improve glycemic control, often in combination with diet and exercise and sometimes alongside other antidiabetic medications (e.g., metformin, insulin, or SGLT2 inhibitors).

1. What 0.75 mg Means

• Starting Dose: The usual starting dose for most adults is 0.75 mg once per week, injected subcutaneously (under the skin) in the abdomen, thigh, or upper arm.
• Titration: After 4 weeks, many patients are switched to the maintenance dose of 1.5 mg once weekly, unless the treating clinician determines the 0.75 mg dose is adequate for their glycemic goals.
• Missed Injection: If you miss a dose, you can inject it as soon as you remember. If it’s more than 4 days after the scheduled injection, treat it as a new week and start a new 0.75 mg dose (or the maintenance dose if you’re already on it).

2. How to Use It

3. What It Does

• Stimulates GLP‑1 receptors in the pancreas → increases insulin secretion when blood glucose is high.
• Suppresses glucagon → reduces excess glucose production.
• Delays gastric emptying → slows the rise in post‑prandial blood glucose.
• Promotes satiety → can aid in weight loss or weight maintenance in many patients.

4. Common Side Effects

Most people tolerate the drug well, and side effects often improve after the first few weeks.

5. What to Avoid / Interactions

• Other GLP‑1 agonists or DPP‑4 inhibitors: Do not combine with other GLP‑1 drugs.
• Surgical procedures: Some surgeons recommend stopping Trulicity 1–2 weeks before major surgery to reduce the risk of hypoglycemia and delayed gastric emptying.
• Medications that slow gastric emptying: May increase GI side effects.
• Alcohol: Can increase the risk of hypoglycemia when used with other glucose‑lowering agents.

6. Who Should Not Use Trulicity

7. Storage & Expiration

• Before first use: Keep refrigerated (2–8 °C). Do NOT freeze.
• After first use: Store at room temperature (≤25 °C). Do not exceed 30 days after the first injection.
• Do not expose to temperatures >30 °C or freeze.
• Expiration: Check the vial/pen label for the expiry date. Do not use beyond this date.

8. Cost & Insurance

• Many insurance plans cover Trulicity, but copayments can vary.
• Ask your pharmacist about patient assistance programs or manufacturer coupons if cost is a concern.

9. Monitoring

• Blood glucose: Check daily or as directed by your provider.
• A1C: Typically monitored every 3–6 months to assess long‑term control.
• Weight: Track changes; many patients experience modest weight loss.
• Blood pressure & lipids: Monitor as part of comprehensive diabetes care.

10. When to Seek Medical Help

• Severe abdominal pain (possible pancreatitis)
• Signs of an allergic reaction (rash, itching, swelling of face/lips, severe dizziness)
• Unexplained weight loss or nausea lasting >1 week
• Persistent or worsening hypoglycemia despite adjustment of other medications

Quick Recap

• Dose: 0.75 mg once weekly (start dose); usually titrated to 1.5 mg after 4 weeks.
• Use: Once‑weekly subcutaneous injection.
• Key Benefits: Improves fasting and post‑prandial glucose, promotes weight loss, low risk of hypoglycemia when not combined with insulin/sulfonylureas.
• Common Side Effects: GI upset, injection‑site reactions, mild hypoglycemia risk.
• Contraindications: Type 1 diabetes, known allergy, pregnancy/lactation (use with caution).

Anything else you’d like to know?
I’m happy to help with more details about dosing schedules, insurance tips, or how it fits into an overall diabetes management plan.